Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcoma
D’ Angelo, Sandra P., Mahoney, Michelle R., Van Tine, Brian A., Adkins, Douglas R., Perdekamp, Maria T. Grosse, Condy, Mercedes M., Luke, Jason J., Hartley, Eliza Woodward, Antonescu, Cristina R., TapVolume:
75
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-015-2689-8
Date:
March, 2015
File:
PDF, 502 KB
english, 2015